DeepMatter Group PLC Directorate Change (7219D)
June 28 2019 - 1:01AM
UK Regulatory
TIDMDMTR
RNS Number : 7219D
DeepMatter Group PLC
28 June 2019
28 June 2019
DeepMatter Group plc
("DeepMatter", the "Company" or the "Group")
Directorate Change
As previously announced, DeepMatter (AIM: DMTR), the AIM-quoted
company focusing on digitizing chemistry, is pleased to confirm the
appointment of Lauren Lees to the Board as Financial Director with
immediate effect.
Lauren is a chartered accountant who qualified with Grant
Thornton UK LLP and has been Financial Controller at the Company
since October 2018, during which time she has played a significant
role in the strategic and operational development of the Group.
Previously, she was Financial Controller at BioOutsource Limited, a
high growth start-up life science company which was acquired by
Sartorius AG in 2015, and then rebranded as Sartorius Stedim
BioOutsource Limited, serving on both the local management and
strategy teams. Lauren takes over as Financial Director from
Michael Bretherton who has stepped down with immediate effect.
Lauren Rachel Lees, aged 31, holds no other current
directorships, nor has she held a directorship during the five
years prior to her appointment. She holds no interest in ordinary
shares of the Company. There are no further disclosures to be made
in accordance with Rule 17 and paragraph (g) of Schedule 2 of the
AIM Rules for Companies.
Mark Warne, Chief Executive Officer of DeepMatter,
commented:
"We are grateful for the significant contribution Michael has
made to the business and wish him well in his future endeavours. We
are also pleased to welcome Lauren to her new role as Financial
Director. Her positive influence on not only the finance
department, but also the broader Group so far has been significant,
and we look forward to benefitting from her skills and experience
further at Board level."
Ends
For further information:
DeepMatter Group plc T: 0141 548 8156
Mark Warne, Chief Executive Officer
Shore Capital (Nominated Adviser and T: 020 7601 6100
Broker)
Tom Griffiths
David Coaten
Alma PR T: 020 3405 0209
Caroline Forde deepmatter@almapr.co.uk
Susie Hudson
Jessica Joynson
About DeepMatter:
DeepMatter's long term strategy is to integrate chemistry with
technology, thereby enabling a greater use of artificial
intelligence and reaching a point where chemicals can be
autonomously synthesised through robotics. In the near term this
involves the provision of an integrated software, hardware and
artificial intelligence enabled platform, DigitalGlassware(TM), to
scientists across research and process development sectors.
The DigitalGlassware(TM) platform allows chemistry experiments
to be accurately and systematically recorded, coded and entered
into a shared data cloud. The platform is designed to enable
chemists to work together effectively; sharing the details of their
experiments from anywhere and in real-time, so that work is not
needlessly duplicated, time and money wasted, and ultimately so new
discoveries may be made faster.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAPGUCAQUPBGAM
(END) Dow Jones Newswires
June 28, 2019 02:01 ET (06:01 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Apr 2024 to May 2024
Deepmatter (LSE:DMTR)
Historical Stock Chart
From May 2023 to May 2024